1. Home
  2. Analysis
  3. Ritalin
  4. Facial-palsy-aggravated

Ritalin and Facial palsy aggravated - a phase IV clinical study of FDA data

Summary:

Facial palsy aggravated is reported as a side effect among people who take Ritalin (methylphenidate hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for 10+ years also take Xyrem, and have Cataplexy.

The phase IV clinical study analyzes which people have Facial palsy aggravated when taking Ritalin. It is created by eHealthMe based on reports of 26,179 people who have side effects when taking Ritalin from the FDA, and is updated regularly.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.

What is Facial palsy aggravated?

Facial palsy aggravated (paralysis of face nerve) is found to be associated with 676 drugs and 776 conditions by eHealthMe. Check the latest studies of Facial palsy aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

26,179 people reported to have side effects when taking Ritalin.
Among them, 24 people (0.09%) have Facial palsy aggravated.

Could Ritalin cause Facial palsy aggravated?

Among these 24 people:

How long have people been on Ritalin when they have Facial palsy aggravated? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 33.33 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 66.67 %

What is the gender of people who have Facial palsy aggravated when taking Ritalin? *

  • female: 47.83 %
  • male: 52.17 %

What is the age of people who have Facial palsy aggravated when taking Ritalin? *

  • 0-1: 0.0 %
  • 2-9: 5.56 %
  • 10-19: 27.78 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 22.22 %
  • 50-59: 22.22 %
  • 60+: 22.22 %

What are other drugs people take besides Ritalin? *

  1. Xyrem: 5 people, 20.83%
  2. Zoloft: 4 people, 16.67%
  3. Synthroid: 4 people, 16.67%
  4. Prozac: 3 people, 12.50%
  5. Nuvigil: 3 people, 12.50%
  6. Ocrevus: 3 people, 12.50%
  7. Cozaar: 2 people, 8.33%
  8. Celebrex: 2 people, 8.33%
  9. Melatonin: 2 people, 8.33%
  10. Premarin: 2 people, 8.33%

What are other side effects people have besides Facial palsy aggravated? *

  1. Hypoaesthesia (reduced sense of touch or sensation): 3 people, 12.50%
  2. Chest Pain: 3 people, 12.50%
  3. Fatigue (feeling of tiredness): 3 people, 12.50%
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 8.33%
  5. Stress And Anxiety: 2 people, 8.33%
  6. High Blood Pressure: 2 people, 8.33%
  7. Herpes Virus Infection: 2 people, 8.33%
  8. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 2 people, 8.33%
  9. Oropharyngeal Pain: 2 people, 8.33%
  10. Panic Disorder: 2 people, 8.33%

What are the existing conditions these people have? *

  1. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 8.33%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 8.33%
  3. Stress And Anxiety: 1 person, 4.17%
  4. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.17%
  5. Psychomotor Hyperactivity (feelings of extreme restlessness): 1 person, 4.17%
  6. Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 1 person, 4.17%
  7. Drowsiness: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin and have Facial palsy aggravated?

- Check whether Facial palsy aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ritalin:

Facial palsy aggravated treatments and more:

How severe was Facial palsy aggravated and when was it recovered:

Expand to all the drugs that have ingredients of methylphenidate hydrochloride:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Facial palsy aggravated:

Browse all the conditions that are associated with Facial palsy aggravated:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride (the active ingredients of Ritalin) and Ritalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.